The effects of the 5-hydroxytryptamine (5-HT3) receptor antagonist, ICS 205-930 (tropisetron), on basal and 5-HT induced jejunal secretion ofwater and electrolytes were examined using a double blind, randomised crossover design. In seven healthy volunteers steady* state perfusions of the proximal jejunum were performed twice with the Loc-IGut tube after 5+5 mg ICS 205-930 or placebo capsules were given. After equilibration for 60 minutes and completion of a 120 minute basal period 5-HT (10 ,ug/kgxmin intravenously) was infused for 120 minutes. Net water absorption (mean (SEM)) in the basal period was 0-55 (0.84) ml/cmxh and 0 74 (0.72) ml/cmxh after placebo and ICS 205-930, respectively (p>O-OS). Infusion of 5-HT caused significant net secretion of water after placebo (2 05 (0 58) ml/cmxh; p<0.02) as weli as ICS 205-930 (2-60 (0.89) ml/cmxh; p<0 05). As ICS 205-930 excerted no effects on either basal or 5-HT induced water and electrolyte transport in the intact human jejunum the compound is probably not efficacious as an anti-secretory drug in patients with 5-HT induced diarrhoea. (Gut 1994; 35: 637- 
Numerous in vivo studies have shown that exogenous 5-hydroxytryptamine (5-HT) elicits secretion of chloride and water in the small intestine of rodents,' cats,4 dogs,5 and pigs (unpublished data) as well as in the human small intestine.6 Jejunal secretion elicited by bacterial toxins, such as cholera toxin79 and Escherichia coli heat stable enterotoxin,"' by Entamoeba histolytica," and by antigens in sensitised animals'2 3 is mediated, in part at least, by local release of 5-HT from enterochromaffine cells7 and immune cells, such as mast cells and phagocytes in the lamina propria.'3 These cells play an important part in intestinal secretion through the release of prostaglandins'3'5 by stimulation of the enterocyte2 'll or activation of neural reflex pathways. '4 18 More specifically, 5-HT3 receptors have been implicated in the in vitro secretory response to both exogenous 5-HT"' 2 (15 ,uCi/l) was added as a non-absorbable marker. Aspiration was by gravity drainage from ports next to the balloons. The aspirates were collected in 20 minute periods and immediately frozen to -20°C until analysis. The volume of the study segment was about 80 ml. 26 A second double lumen tube was positioned in the antrum of the stomach for aspiration of gastric juice. Phenol red (50 mg/l; 154 mM NaCI) was infused at a rate of 1 ml/min into the stomach and analysed in the effluents from the closed jejunal segment to rule out leakage.
After a 60 minute equilibration period, during which the closed jejunal segment was emptied for mucus, as judged from the appearance of clear aspirates, samples were collected in consecutive 20 minute periods. Both during the equilibration period and the control period (120 minutes) isotonic saline was infused intravenously at a rate of 50 ml/h, when the infusion solution was changed to 5-HT (5-hydroxytryptamine creatinine sulphate (Serva, Heidelberg, Germany) dissolved in isotonic saline (10 rig/ kgxmin, 50 ml/h intravenously) for 120 minutes. spectrophotometrically at 560 nm after alkalisation (pH 11) with a Na3PO4 buffer.
DETERMINATION OF WATER AND ELECTROLYTE TRANSPORT
Net water and electrolyte transport rates were determined as described by Knutson et al26 and expressed as ml/cmxh and mmol/cmx h, respectively. Net absorption was shown by a positive sign and net secretion by a negative sign.
STATISTICAL ANALYSES
All results are given as means with standard errors (SEM). To discover if analysis of variance could be applied the results were tested for carryover and period effects on treatment outcomes using Student's t test. This was done on the assumption that there were no residual effects. Pairs (Figs 1 and 2 ). Net secretion of water in response to 5-HT infusion was seen in all subjects who had received placebo capsules (2 05 (0 58) ml/cm xh; p<002) and in all but one subject after ICS 205-930 capsules (2-60 (0-89) ml/cmxh; p<0 05) (Figs 1 and 2 ), but there was no difference (p>005) in secretory response between active and inactive treatment.
Also net absorption of sodium, potassium, and chloride was insignificantly (p>005) different from zero during basal periods after placebo and chloride was not changed (p>005) by ICS 205-930 (Fig 3) .
ADVERSE EVENTS
No adverse events from treatment with ICS 205-930 or placebo were reported and no abnormalities or significant differences in laboratory screening values were seen before or after the study, respectively. The intravenous infusion of 5-HT caused pain at the infusion site and vasodilation. Minor oedema of the hands and flushing were seen in two cases. Most subjects reported nausea and abdominal discomfort, which was relieved by withdrawing a few ml of air from the balloons. All symptoms disappeared immediately after the 5-HT infusion was stopped. No effects on blood pressure or heart rate were registered.
Discussion
Intestinal water and electrolyte transport is controlled by the enteric nervous system, comprising intrinsic and extrinsic neurons, in addition to neuroendocrine cells, hormones, bacterial enterotoxins, and the immune system, all of which are anatomically and functionally intermingled. 'l'5 The neurotransmitter, 5-HT, is present predominantly in the enterochromaffine cells along the entire small intestine, but a minor part is found in the myenteric plexus and in the mast cells situated in the lamina propria.'3 The 5-HT induced, calcium dependent' 2 secretion is the result of inhibition of electroneutral sodium chloride absorption and stimulation of chloride secretion' 24 and is independent of changes in intestinal blood flow or permeability.
In this study we used a glucose free perfusion solution to permit comparison with previously published data on 5-HT induced jejunal secretion in humans. 6 The results confirm that exogenous 5-HT induces jejunal secretion of water and electrolytes, as previously shown in vivo in various experimental animal models' and in humans. 6 The results also show that 10 mg of ICS 205-930 (tropisetron) given orally has no effect on either basal water and electrolyte transport or 5-HT induced secretion. In a model of human secretory diarrhoea, in which 6-25 Fg cholera toxin given intrajejunally induced a secretory response of the same magnitude as seen in our study, ketanserin given parenterally and ICS 205-930 in combination enhanced the secretory effects of cholera toxin, while ICS 205-930 had no effect on basal water transport (unpublished data). In addition, ICS 205-930 failed to inhibit the secretory effects of cholera toxin in the pig small intestine in vivo and induced secretion at high rates (unpublished data).
Our results as well as those of others seen in pigs and in humans are not comparable with those obtained in vivo in rodents,49'022 because higher doses of the 5-HT receptor antagonists were given intravenously in the latter studies. In this study ICS 205-930 was given 12 hours and one hour before the experiment to ensure absorption and stable plasma concentrations of the drug. The dose is equivalent to that given intravenously by Eherer et al (unpublished data) who saw no effect on net water absorption during control periods and, contrary with what has been seen in rodent experiments, an enhancement rather than inhibition of cholera toxin induced secretion by ICS 205-930. Thus, the lack of effect on basal and 5-HT stimulated water and electrolyte transport is probably not explained by insufficient absorption of the drug. The optimum therapeutic dose for prevention of nausea and vomiting associated with chemotherapy is 5 mg. on net water transport -that is, type II error, exceeding 1 5 SD was less than 20%. Thus, the species differences seen between rodents and humans are probably not explained by differences in dose or route of administration. Net absorption of water and electrolytes is the most common finding in perfusion studies of the human small intestine using the triple lumen technique6 or the double lumen technique with a proximal occluding balloon (unpublished data). In this study net water absorption was minimal and insignificantly different from zero (p>0 05). Minimal net secretion of water occurred in several subjects during basal conditions, both after placebo and ICS 205-930 (Fig 1) . This discrepancy between our previous study using the same perfusion solution,6 but the triple lumen technique, cannot be explained by the absence of glucose in the perfusate. It 
